Hosted by the American Counseling Association for provider continuing education, BreakThrough
One recent study conducted by Eli Lilly (one of the drugs manufacturers) found that patients with obesity who took the weight loss drug, Zepbound, for a year saw an almost 60 percent decrease in their sleep apnea symptoms
In addition, it has been observed that levels of long-chain acylcarnitines were associated with incident hyperuricemia [23]
When asked for his perspective on the fast, SL described it as something that needed to be done and stated he was satisfied with the results
Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ
We understand that sustainable weight loss is a marathon, not a sprint, and that achieving your goals requires a combination of science, empathy, and a transparent approach